Using genomic polymerase chain reaction (PCR), conserved FLT3 mutations between species have been demonstrated in both the canine GL-1 cell line and in clinical specimens of canine B-cell lymphoma. The gene discussed is FLT3; the disease is B-cell non-Hodgkin lymphoma.